Oxolipidomics profile in major depressive disorder: Comparing remitters and non-remitters to repetitive transcranial magnetic stimulation treatment.
Hannah StirtonBenjamin P MeekAndrea L EdelZahra SolatiArun SurendranHarold AukemaMandana ModirroustaAmir RavandiPublished in: PloS one (2021)
Certain categories of OxPCs may be useful predictive biomarkers for response to rTMS treatment in MDD. Given that elevated oxidized lipids may indicate higher levels of oxidative stress and inflammation in the brain, patients with this phenotype of depression may be more receptive to rTMS treatment.